Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

NCT00658684 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer